Quick Answer
Editas Medicine, Inc. reported Total Assets of $186.53 million for fiscal year 2025.
Editas Medicine, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $186.53M | -45.4% |
| 2024 | $341.59M | -31.6% |
| 2023 | $499.15M | -2.9% |
| 2022 | $514.32M | -24.1% |
| 2021 | $677.48M | +18.3% |
| 2020 | $572.60M | +12.5% |
| 2019 | $508.88M | +21.1% |
| 2018 | $420.39M | +12.6% |
| 2017 | $373.26M | +62.9% |
| 2016 | $229.18M | +53.4% |
| 2015 | $149.36M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $201.75M | -38.4% | -4.2% |
| June 30, 2025 | $210.58M | -45.3% | -20.1% |
| March 31, 2025 | $263.65M | -40.1% | -22.8% |
| December 31, 2024 | $341.59M | -31.6% | +4.3% |
| September 30, 2024 | $327.57M | -35.1% | -14.9% |
| June 30, 2024 | $384.80M | -29.0% | -12.6% |
| March 31, 2024 | $440.35M | -5.1% | -11.8% |
| December 31, 2023 | $499.15M | -2.9% | -1.1% |
- Editas Medicine, Inc. showed a decrease of -45.4% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Editas Medicine, Inc.’s total assets has grown by 24.9% (from $149.36 million to $186.53 million).
- The most recent figure is from Editas Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: